NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Canwell Biotech Ltd.

Canwell Biotech Ltd.

Private
GuangzhouHealthcare & Life Scienceshttp://canwellbiotech.com/

Last Round

Series A

Extension

Aug 1, 2022

Total Funding Raised

$46.2M

Company Overview

Canwell Biotech Ltd. is a biotechnology company that focuses on the research, development, and commercialization of innovative anti-tumor immunotherapies, including antibody-drug conjugates (ADCs) and cancer vaccines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCimmunotherapycancer vaccinesmall molecule-drug conjugateSMDCdrug discoverybiotechsolid tumor treatmentTLR7 agonistclinical-stage biopharmatargeted cancer therapyprecision medicinedrug licensingnext-gen oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Canwell Biotech Ltd. Comparables

Compare Canwell Biotech Ltd. with similar companies based on industry and business-model similarity.

Canwell Biotech Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Callio Therapeutics
87%
Eli Lilly and Company
83%
Coherent Biopharma
82%

Canwell Biotech Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionAug 1, 2022
Series AMar 18, 2022
Early FundingDec 1, 2020

Canwell Biotech Ltd. Investors

Notable investors and investment history

Canwell Biotech Ltd. investors
InvestorRounds
China Capital Management Co., Ltd.Series A
China Science and Technology Industry Investment ManagementSeries A, Early Funding
SDIC Venture CapitalSeries A Extension
Jiuyo Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2020

    Raised capital from 国科投资.

Canwell Biotech Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Canwell Biotech Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Canwell Biotech Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Year Founded2018
Last FundingAug 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.